Jonathan Moses

8PUBLICATIONS
31CO-AUTHORS
Infant and child healthImmunogenetics (incl. genetic immunology)Child and adolescent developmentAdolescent healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 12, 2026
Risk factors for early-onset venous thromboembolism in pediatric inflammatory bowel disease.

|Feb 06, 2026
Integrating intestinal ultrasound into routine clinical care improves prediction of biochemical disease activity in pediatric inflammatory bowel disease.

Perseus V Patel, Destiny J Zuniga, Alka Goyal

|May 02, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.

Jeremy Adler, Joseph A Galanko, Rana Ammoury

|May 01, 2025
Intensified Upadacitinib Dosing for Adolescent Patients with Acute Severe Ulcerative Colitis.

Perseus V Patel, Martina Rigmaiden, Alka Goyal

|Oct 17, 2024
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.

Jonathan Moses, Jeremy Adler, Shehzad A Saeed

|Mar 06, 2024
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease.

Dawn R Ebach, Traci W Jester, Joseph A Galanko

Pageof 2

Frequent Collaborators

3 joint publications

Dawn R Ebach

3 joint publications

Joseph A Galanko

3 joint publications

Ann M Firestine

3 joint publications

Rana Ammoury